GS1 adoption is vital as life sciences and healthcare companies focus on reducing operating costs, increasing efficiency and improving patient safety. Software companies are rising to the challenge as the life sciences and healthcare industries focus on reducing operating costs and increasing efficiency in these tough times. (more…)
Archive for March, 2009
Mar 19th
21 CFR Part 11 Labeling Systems
Everyone in the biotech and life sciences industries knows that 21 CFR Part 11 is not a new requirement ‘ it dates back to 1997, and has remained pretty much unchanged since then. Only its scope has changed.
Initially, the new requirement was widely ignored by both the industry and the FDA. This indifference was not intentional, but can be attributed to a pure lack of understanding by both the industry and the regulators. (more…)
Mar 10th
Counterfeit Drugs Penetrate Deeper
A recent European conference hosted by TOPRA, held to discuss the legislative changes outlined in the “Pharma Package” published by the European Commission on 10th December 2008 has outlined the deep penetration of counterfeit drugs within the pharmaceutical supply chain.
Mar 4th
Labeling Seminar Q&A Session
The following post is a transcript of the Q&A session held recently at the labeling seminar we hosted in Philidelphia on 20th February 2009. It’s a frank discussion between representatives from leading pharmaceutical companies and myself, Product Manager for PRISYM ID. (more…)
